AAREYDRUGS.NSAAREYDRUGS.NSNSE
Loading
Operating Expenses Over TimeStrong
Percentile Rank73
3Y CAGR+60.7%
5Y CAGR+84.8%
Studio
Year-over-Year Change

Expenses from normal business operations (SG&A, R&D, etc.)

3Y CAGR
+60.7%/yr
vs -26.0%/yr prior
5Y CAGR
+84.8%/yr
Recent deceleration
Acceleration
+86.7pp
Accelerating
Percentile
P73
Within normal range
vs 5Y Ago
21.5x
Strong expansion
Streak
2 yr
Consecutive declineStrong
PeriodValueYoY Change
TTM$85.13M-3.5%
2025$88.25M-15.0%
2024$103.80M+406.1%
2023$20.51M-79.7%
2022$100.87M+2450.2%
2021$3.96M-94.8%
2020$75.52M+10.5%
2019$68.33M+71.4%
2018$39.86M-56.3%
2017$91.27M-